Physician profile
William E Duvall
NPI 1114210739
$640.30
in general payments reported to CMS, 2019-2025
9 companies · $63.07 in 2025
The $63.07 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.81 · 2021: $44.90 · 2022: $75.93 · 2023: $172 · 2024: $219 · 2025: $63.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $169.84 | 2019-2025 | Bridion |
| Atricure, INC. | $143.39 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $113.13 | 2023-2025 | Iovera, Exparel, Zilretta |
| Eagle Pharmaceuticals, INC. | $65.01 | 2023-2024 | |
| Chiesi USA, INC. | $45.36 | 2024-2025 | Cleviprex |
| La Jolla Pharmaceutical Company | $41.55 | 2022-2023 | Giapreza |
| Fisher & Paykel Healthcare INC | $37.40 | 2024 | Fisher & Paykel Healthcare |
| Trevena, INC. | $13.67 | 2022 | |
| B. Braun Medical INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Duvall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.